When CDK4/6 is inhibited, it restricts tumor cells from entering the next stage of mitosis (Piezzo et al., 2020), increasing evidence suggests that dysregulation of long-chain non-coding RNA (lncRNAs) is closely related to the occurrence and progression of breast cancer. Here, CDK4 is linked to breast carcinoma.